Certain Convertible Debentures of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2023.
March 20, 2023
Share
Certain Convertible Debentures of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2023. These Convertible Debentures will be under lockup for 187 days starting from 15-SEP-2022 to 21-MAR-2023.
Details:
Executive officers, directors following this offering and other security holders of five percent (5%) or more have agreed not to offer, sell, agree to sell, directly or indirectly, or otherwise dispose of any shares of our common stock for a period of six months following the closing of this offering.
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Companyâs Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Companyâs trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.
KNOW LABS, INC. 
